RKDA (Arcadia Biosciences) Moat Score: 3/10 (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RKDA Arcadia Biosciences Inc RKDA
43 GF Score
Price $0.56
GF Value $2.84
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Arcadia Biosciences Moat Score?

Arcadia Biosciences RKDA -18.59% 43 Moat Score is 3 as of Aug. 13, 2026. GuruFocus rates RKDA with a GF Score™ of 43/100 and a GF Value™ of $2.84 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 2,043 Consumer Packaged Goods companies, Arcadia Biosciences ranks better than 91.04% on this metric.

Arcadia Biosciences has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Arcadia Biosciences has No Moat: Arcadia Biosciences has some valuable intellectual property in agricultural biotechnology, but it lacks market leadership and significant customer switching costs. The company faces intense competition and has limited brand strength, resulting in a weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Arcadia Biosciences might have No Moat - Very weak/transient advantages.

Arcadia Biosciences  (NAS:RKDA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Arcadia Biosciences Moat Score Related Terms

RKDA vs ORISF, ARRT, CIMG: Moat Score Comparison

For the Packaged Foods subindustry, Arcadia Biosciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arcadia Biosciences Moat Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Moat Score distribution charts can be found below:

* The bar in red indicates where Arcadia Biosciences's Moat Score falls into.


RKDA
43GF Score
Arcadia Biosciences Inc RKDA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Arcadia Biosciences (RKDA) has a Moat Score of 3 as of Aug. 13, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Arcadia Biosciences ranks #183 out of 2043 companies in the Consumer Packaged Goods industry, placing it in the top 9%.
Is Arcadia Biosciences' Moat Score too high?
Arcadia Biosciences' current Moat Score is 3. Based on the distribution chart, Arcadia Biosciences ranks #183 out of 2043 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Arcadia Biosciences has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' Moat Score compare to ORISF and ARRT?
According to the Consumer Packaged Goods industry distribution chart, Arcadia Biosciences ranks #183 out of 2043 companies for Moat Score. This places Arcadia Biosciences in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Consumer Packaged Goods company?
A good Moat Score depends on the Consumer Packaged Goods industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Arcadia Biosciences's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Arcadia Biosciences (RKDA) is currently considered Possible Value Trap. The stock's GF Value™ is $2.84, compared to a current price of $0.56 — trading 80.3% below its estimated fair value. The current Moat Score is 3. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Arcadia Biosciences (RKDA), the current Moat Score is 3 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcadia Biosciences (RKDA) Overvalued in 2026?

Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued. The current stock price of $0.56 is trading 80.3% below its estimated GF Value™ of $2.84. GuruFocus considers Arcadia Biosciences to be Possible Value Trap.

Key valuation signals for RKDA:

  • Moat Score: 3
  • GF Value™: $2.84 vs. price of $0.56 (80.3% below fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the RKDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arcadia Biosciences Business Description

Address 5950 Sherry Lane, Suite 2000, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score

Get the complete analysis for RKDA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$2.84
GF Value